Cassava Sciences (SAVA) Insider Trading & Ownership $2.73 +0.12 (+4.60%) As of 02:57 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Cassava Sciences (NASDAQ:SAVA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage9.00%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$246,308.00 Get SAVA Insider Trade Alerts Want to know when executives and insiders are buying or selling Cassava Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SAVA Insider Buying and Selling by Quarter Cassava Sciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/29/2024Eric SchoenCFOSell59,800$3.86$230,828.00 11/29/2024James William KupiecInsiderSell4,000$3.87$15,480.00 (Data available from 1/1/2013 forward) SAVA Insider Trading Activity - Frequently Asked Questions Who is on Cassava Sciences's Insider Roster? The list of insiders at Cassava Sciences includes Eric Schoen, James William Kupiec, Richard Barry, and Sanford Robertson. Learn more on insiders at SAVA. What percentage of Cassava Sciences stock is owned by insiders? 9.00% of Cassava Sciences stock is owned by insiders. Learn more on SAVA's insider holdings. Which Cassava Sciences insiders have been buying company stock? The following insiders have purchased SAVA shares in the last 24 months: Richard Barry ($366,206.79), and Sanford Robertson ($523,500.00). How much insider buying is happening at Cassava Sciences? Insiders have purchased a total of 63,526 SAVA shares in the last 24 months for a total of $889,706.79 bought. Which Cassava Sciences insiders have been selling company stock? The following insiders have sold SAVA shares in the last 24 months: Eric Schoen ($230,828.00), and James William Kupiec ($15,480.00). How much insider selling is happening at Cassava Sciences? Insiders have sold a total of 63,800 Cassava Sciences shares in the last 24 months for a total of $246,308.00 sold. Cassava Sciences Key ExecutivesMr. Remi Barbier (Age 64)Founder, Chairman, President & CEO Compensation: $1.2MMr. Eric J. Schoen (Age 56)Chief Financial Officer Compensation: $460k1 recent tradesMr. R. Christopher Cook (Age 60)Senior VP, Company Secretary & General Counsel Compensation: $425kDr. James W. Kupiec M.D. (Age 71)Chief Medical Officer Compensation: $435kDr. George Thornton Ph.D.Senior Vice President of TechnologyMr. Michael ZamlootSenior Vice President of Technical OperationsDr. Michael Marsman Pharm.D.Senior Vice President of Regulatory AffairsDr. Lindsay H. Burns Ph.D.Senior Vice President of Neuroscience More Insider Trading Tools from MarketBeat Related Companies Mereo BioPharma Group Insider Trading Rapport Therapeutics Insider Trading Ginkgo Bioworks Insider Trading Entrada Therapeutics Insider Trading Xeris Biopharma Insider Trading Tourmaline Bio Insider Trading Altimmune Insider Trading Mind Medicine (MindMed) Insider Trading Stoke Therapeutics Insider Trading Sage Therapeutics Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:SAVA) was last updated on 1/15/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cassava Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cassava Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
